This eGFR calculator estimates kidney function with the 2021 CKD-EPI equations recommended by the National Kidney Foundation and the American Society of Nephrology, which no longer use race. Enter age, sex and serum creatinine in mg/dL or µmol/L for the standard creatinine equation, and add cystatin C to use the more accurate combined creatinine–cystatin C equation. The result is staged from G1 to G5, and with a urine albumin-to-creatinine ratio it is placed on the colour-coded KDIGO grid that shows the risk of progression. Enter a body surface area to convert eGFR into an absolute mL/min value for drug dosing. Lab staff and clinicians can paste or drop a lab export and every patient is staged at once. It is free, runs entirely in your browser, and no patient data is uploaded.
| Creatinine (mg/dL) | Age | Male | Female |
|---|---|---|---|
| 0.8 | 40 | 115 | 95 |
| 1.0 | 40 | 98 | 73 |
| 1.0 | 70 | 81 | 61 |
| 1.5 | 60 | 53 | 40 |
| 2.5 | 60 | 29 | 21 |
90 mL/min/1.73 m² or more is normal (G1); 60–89 is mildly decreased (G2). Below 60 for more than three months indicates chronic kidney disease.
The NKF–ASN task force recommended removing the race coefficient because race is a social, not biological, category; the 2021 equations were refitted without it.
When creatinine may mislead, for example in very muscular or frail patients, amputees or people on special diets. The combined equation is more accurate than either marker alone.
It combines the GFR stage with albuminuria (A1–A3) to show the risk of kidney disease getting worse: low, moderate, high or very high.
No. Everything is calculated in your browser.
eGFR is calculated with the 2021 CKD-EPI creatinine equation, 142 × min(Scr/κ, 1)^α × max(Scr/κ, 1)^−1.200 × 0.9938^age × 1.012 if female (κ 0.7 or 0.9; α −0.241 or −0.302), the same function the site's Clinical Calculators Suite uses. When cystatin C is entered, the 2021 creatinine–cystatin C equation is used instead: 135 × min(Scr/κ, 1)^α × max(Scr/κ, 1)^−0.544 × min(Scys/0.8, 1)^−0.323 × max(Scys/0.8, 1)^−0.778 × 0.9961^age × 0.963 if female (α −0.219 female, −0.144 male). Neither includes a race coefficient. Creatinine in µmol/L is divided by 88.42. The result is staged G1–G5 and, with a urine albumin-to-creatinine ratio, placed on the KDIGO 2012 risk grid (A1 < 30, A2 30–300, A3 > 300 mg/g). An optional BSA de-indexes eGFR to mL/min (× BSA ÷ 1.73) for drug dosing.